Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Sexual & Reproductive Health Drugs Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising population of the elder female demanding medicines
5.1.1.2. Demand for contraceptives to prevent unintended pregnancies
5.1.1.3. High internet penetration and availability of smartphones and laptops
5.1.2. Restraints
5.1.2.1. High cost of treatment and diagnostics
5.1.3. Opportunities
5.1.3.1. Increasing efforts into research and development (R&D) of drugs
5.1.3.2. Growing awareness among ladies about the use of contraceptives
5.1.3.3. Government concerns and initiatives towards women’s health
5.1.4. Challenges
5.1.4.1. Enormous financial costs associated with the clinical services
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Sexual & Reproductive Health Drugs Market, by Drugs Type
6.1. Introduction
6.2. Erectile Dysfunction Drugs
6.3. Gender Dysphoria Drugs
6.4. Hypoactive Sexual Desire Disorder Drugs
6.5. Premature Ejaculation Drugs

7. Sexual & Reproductive Health Drugs Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacy
7.3. Online Pharmacy
7.4. Retail Pharmacy

8. Americas Sexual & Reproductive Health Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Sexual & Reproductive Health Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Sexual & Reproductive Health Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Bayer AG
12.1.2. Bristol Laboratories Ltd.
12.1.3. Church & Dwight Co., Inc.
12.1.4. Diamond Products
12.1.5. Ferring B.V.
12.1.6. Janssen Pharmaceutical Inc.
12.1.7. Merck & Co., Inc.
12.1.8. Novartis AG
12.1.9. Pfizer Inc.
12.1.10. Reckitt Benckiser Group PLC
12.1.11. Teva Pharmaceutical Industries Ltd.
12.1.12. Viatris Inc.
12.1.13. Viramal Limited
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET RESEARCH PROCESS
FIGURE 2. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET DYNAMICS
FIGURE 7. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2022 VS 2030 (%)
FIGURE 8. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 10. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 6. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY ERECTILE DYSFUNCTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY GENDER DYSPHORIA DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY HYPOACTIVE SEXUAL DESIRE DISORDER DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY PREMATURE EJACULATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 11. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. CANADA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 22. CANADA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. MEXICO SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 24. MEXICO SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. CHINA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 34. CHINA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. INDIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 36. INDIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. JAPAN SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 40. JAPAN SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. THAILAND SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 52. THAILAND SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 59. DENMARK SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. EGYPT SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 61. EGYPT SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. FINLAND SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 63. FINLAND SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. FRANCE SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 65. FRANCE SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. GERMANY SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 67. GERMANY SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. ITALY SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 71. ITALY SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. NORWAY SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 77. NORWAY SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. POLAND SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 79. POLAND SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. QATAR SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 81. QATAR SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. SPAIN SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. TURKEY SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 95. TURKEY SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 101. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 102. SEXUAL & REPRODUCTIVE HEALTH DRUGS MARKET LICENSE & PRICING